# Correction: Integrating network pharmacology and transcriptomics to identify solasonine’s anti-osteosarcoma targets and experimental validation

**Authors:** Daihao Wei, Minyu Li, Dawei Chu, Jiandang Shi

PMC · DOI: 10.3389/fonc.2025.1682157 · Frontiers in Oncology · 2025-09-29

## Full-text entities

- **Diseases:** osteosarcoma (MESH:D012516)
- **Chemicals:** solasonine (MESH:C026608)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12516817/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12516817/full.md

---
Source: https://tomesphere.com/paper/PMC12516817